Report cover image

Global Nuclear Medicine Market Size study, by Type (Diagnostic, Therapeutic, Others), by Application (Neurology, Thyroid, Oncology), by Procedures, by End User, and Regional Forecasts 2024-2034

Publisher Factview Research
Published Jun 27, 2025
Length 285 Pages
SKU # FAVR20179477

Description

The Global Nuclear Medicine Market is currently valued at approximately USD 5.8 billion in 2024 and is poised to exhibit a significant compound annual growth rate (CAGR) of 11.7% over the forecast period from 2024 to 2034. The burgeoning field of nuclear medicine, a critical segment within medical imaging and therapeutic technologies, is redefining diagnostic and treatment protocols. By utilizing radioactive isotopes, this technology provides unparalleled precision in detecting, monitoring, and treating complex conditions, such as cancers, neurological disorders, and thyroid abnormalities.

With advancements in technology, nuclear medicine is evolving rapidly, characterized by a shift towards hybrid imaging systems and targeted radiotherapies. Diagnostics, particularly Single Photon Emission Computed Tomography (SPECT) using Technetium and Positron Emission Tomography (PET) employing F-18 isotopes, have become essential tools in clinical decision-making. Therapeutics, leveraging beta and alpha emitters like Yttrium-90 and innovative brachytherapy solutions, are enhancing patient outcomes. These breakthroughs are augmented by substantial investment in research, bolstering the market's ability to cater to an array of medical challenges with heightened accuracy and efficacy.

The global market's growth trajectory is driven by rising incidences of chronic diseases, such as cancer and neurodegenerative disorders, necessitating advanced diagnostic and therapeutic interventions. Moreover, government initiatives and increased healthcare expenditure globally are catalyzing the adoption of nuclear medicine. However, the high cost of equipment and radioisotopes, coupled with stringent regulatory frameworks governing their use, remains a barrier to market expansion. Despite these challenges, innovations in isotopic production, coupled with collaborations between public and private sectors, present lucrative opportunities for stakeholders.

Regionally, North America dominates the nuclear medicine market, driven by advanced healthcare infrastructure, robust R&D activities, and a high prevalence of chronic diseases. Europe follows closely, benefiting from strong regulatory support and increasing investments in radiopharmaceutical development. The Asia-Pacific region, projected to witness the fastest growth, owes its momentum to rapidly improving healthcare facilities, a growing aging population, and rising awareness about nuclear medicine's therapeutic potential in countries such as India, China, and Japan.

Major market players included in this report are:
  • Siemens Healthineers
  • GE Healthcare
  • Cardinal Health
  • Bayer AG
  • Bracco Imaging S.p.A.
  • Curium Pharma
  • Advanced Accelerator Applications
  • Lantheus Holdings, Inc.
  • Jubilant Radiopharma
  • Nordion (Canada) Inc.
  • Isotopia Molecular Imaging Ltd.
  • Eckert & Ziegler Group
  • Alpha Tau Medical Ltd.
  • Theragnostics Ltd.
  • Telix Pharmaceuticals Limited
The detailed segments and sub-segment of the market are explained below:

By Type:
  • Diagnostic
SPECT

 Technetium

PET

 F-18
  • Therapeutic
Beta Emitters

 Y-90

Alpha Emitters

Brachytherapy

By Application:
  • Neurology
  • Thyroid
  • Oncology
By Procedures:
  • Imaging Procedures
  • Treatment Procedures
By End User:
  • Hospitals and Clinics
  • Academic and Research Institutes
  • Diagnostic Imaging Centers
By Region:

North America
  • U.S.
  • Canada
Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
Latin America
  • Brazil
  • Mexico
Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
Years considered for the study are as follows:
  • Historical year: 2022
  • Base year: 2024
  • Forecast period: 2024 to 2034
Key Takeaways:
  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional-level analysis for each market segment.
  • Detailed analysis of the geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approaches.
  • Analysis of the competitive structure of the market.
  • Demand-side and supply-side analysis of the market.

Table of Contents

285 Pages
Chapter 1. Global Nuclear Medicine Market Executive Summary 1.1. Global Nuclear Medicine Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Application
1.3.3. By Procedures
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Investment Analysis
1.7. Investment Rationale
1.8. Analyst Recommendation & Conclusion
Chapter 2. Global Nuclear Medicine Market Definition and Research Assumptions 2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Nuclear Medicine Market Dynamics 3.1. Market Drivers
3.1.1. Rising Incidence of Chronic Diseases
3.1.2. Advancements in Diagnostic and Therapeutic Technologies
3.1.3. Increased Healthcare Expenditure and Government Initiatives
3.2. Market Challenges
3.2.1. High Cost of Equipment and Radioisotopes
3.2.2. Stringent Regulatory Frameworks
3.3. Market Opportunities
3.3.1. Innovations in Isotopic Production
3.3.2. Collaborations Between Public and Private Sectors
3.3.3. Expansion in Emerging Markets
Chapter 4. Global Nuclear Medicine Market Industry Analysis 4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Nuclear Medicine Market Size & Forecasts by Type 2024-2034 5.1. Segment Dashboard
5.2. Global Nuclear Medicine Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Diagnostic
5.2.1.1. SPECT
5.2.1.1.1. Technetium
5.2.1.2. PET
5.2.1.2.1. F-18
5.2.2. Therapeutic
5.2.2.1. Beta Emitters
5.2.2.1.1. Y-90
5.2.2.2. Alpha Emitters
5.2.2.3. Brachytherapy
5.2.3. Others
Chapter 6. Global Nuclear Medicine Market Size & Forecasts by Application 2024-2034 6.1. Segment Dashboard
6.2. Global Nuclear Medicine Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Neurology
6.2.2. Thyroid
6.2.3. Oncology
6.2.4. Others
Chapter 7. Global Nuclear Medicine Market Size & Forecasts by Procedures 2024-2034 7.1. Segment Dashboard
7.2. Global Nuclear Medicine Market: Procedures Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
7.2.1. Imaging Procedures
7.2.2. Treatment Procedures
7.2.3. Others
Chapter 8. Global Nuclear Medicine Market Size & Forecasts by End User 2024-2034 8.1. Segment Dashboard
8.2. Global Nuclear Medicine Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
8.2.1. Hospitals and Clinics
8.2.2. Academic and Research Institutes
8.2.3. Diagnostic Imaging Centers
8.2.4. Others
Chapter 9. Global Nuclear Medicine Market Size & Forecasts by Region 2024-2034 9.1. North America Nuclear Medicine Market
9.1.1. U.S. Nuclear Medicine Market
9.1.1.1. Diagnostic Breakdown Size & Forecasts, 2024-2034
9.1.1.2. Therapeutic Breakdown Size & Forecasts, 2024-2034
9.1.1.3. Others Breakdown Size & Forecasts, 2024-2034
9.1.1.4. End User Breakdown Size & Forecasts, 2024-2034
9.1.2. Canada Nuclear Medicine Market
9.2. Europe Nuclear Medicine Market
9.2.1. UK Nuclear Medicine Market
9.2.2. Germany Nuclear Medicine Market
9.2.3. France Nuclear Medicine Market
9.2.4. Spain Nuclear Medicine Market
9.2.5. Italy Nuclear Medicine Market
9.2.6. Rest of Europe Nuclear Medicine Market
9.3. Asia-Pacific Nuclear Medicine Market
9.3.1. China Nuclear Medicine Market
9.3.2. India Nuclear Medicine Market
9.3.3. Japan Nuclear Medicine Market
9.3.4. Australia Nuclear Medicine Market
9.3.5. South Korea Nuclear Medicine Market
9.3.6. Rest of Asia Pacific Nuclear Medicine Market
9.4. Latin America Nuclear Medicine Market
9.4.1. Brazil Nuclear Medicine Market
9.4.2. Mexico Nuclear Medicine Market
9.4.3. Rest of Latin America Nuclear Medicine Market
9.5. Middle East & Africa Nuclear Medicine Market
9.5.1. Saudi Arabia Nuclear Medicine Market
9.5.2. South Africa Nuclear Medicine Market
9.5.3. Rest of Middle East & Africa Nuclear Medicine Market
Chapter 10. Competitive Intelligence 10.1. Key Company SWOT Analysis
10.1.1. Siemens Healthineers
10.1.2. GE Healthcare
10.1.3. Cardinal Health
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Siemens Healthineers
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. GE Healthcare
10.3.3. Cardinal Health
10.3.4. Bayer AG
10.3.5. Bracco Imaging S.p.A.
10.3.6. Curium Pharma
10.3.7. Advanced Accelerator Applications
10.3.8. Lantheus Holdings, Inc.
10.3.9. Jubilant Radiopharma
10.3.10. Nordion (Canada) Inc.
10.3.11. Isotopia Molecular Imaging Ltd.
10.3.12. Eckert & Ziegler Group
10.3.13. Alpha Tau Medical Ltd.
10.3.14. Theragnostics Ltd.
10.3.15. Telix Pharmaceuticals Limited
Chapter 11. Research Process 11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us